Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Simcere Pharmaceutical
Biotech
Connecting the dots: Asthma asset aces phase 2b trial
After selling off certain regional rights to rademikibart, Connect Biopharma's mAb has hit the main goal in a phase 2b asthma trial.
Gabrielle Masson
Dec 12, 2023 11:00am
California biotech Connects with Simcere in $141M licensing pact
Nov 21, 2023 11:07am
Lynk’s JAK1 inhibitor improves severity, itching in eczema study
Aug 9, 2023 12:35pm
